Lyra Therapeutics Inc
NASDAQ:LYRA
Lyra Therapeutics Inc
NASDAQ:LYRA
Price:
0.401
USD
-18.16%
Market Closed
Market Cap:
$709.8k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
US |
|
Smart for Life Inc
NASDAQ:SMFL
|
US |
|
Questor Technology Inc
XTSX:QST
|
CA |
|
Fraport AG Frankfurt Airport Services Worldwide
XETRA:FRA
|
DE |
|
Coca-Cola Icecek AS
IST:CCOLA.E
|
TR |
|
Addtech AB
STO:ADDT B
|
SE |
|
Rithm Capital Corp
NYSE:RITM
|
US |
|
John Wiley & Sons Inc
NYSE:WLYB
|
US |
|
Deutsche EuroShop AG
XETRA:DEQ
|
DE |
|
S
|
Setubandhan Infrastructure Ltd
NSE:SETUINFRA
|
IN |
Relative Value
The Relative Value of one
LYRA
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.401 USD,
Lyra Therapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LYRA Relative Value
HIDDEN
Multiples Across Competitors
LYRA Competitors Multiples
Lyra Therapeutics Inc Competitors
Lyra Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
659.4k USD | 1.1 | -0 | 0.7 | 0.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.6 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
